Odyssey Therapeutics holds $35.33 consensus price target
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
Odyssey Therapeutics (NASDAQ:ODTX) carries a consensus "Moderate Buy" rating from ten research firms, with an average 12-month price target of $35.33 versus a current share price of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context